Requires the report on statewide opioid settlements include the amount of funds that have been spent and requires the public be provided information on how much funds have been spent.
Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.
Includes interest earned on the monies obtained by the state through the statewide opioid settlement agreement, in the opioid settlement fund; requires any New York subdivision that receives funds pursuant to an opioid settlement agreement to spend interest earned on such funds on approved uses.
Clarifies that certain provisions related to statewide opioid settlement agreements shall cover settlements and releases related to any entities involved in the prescription drug marketing, supply and payment chain that may have contributed to the opioid epidemic through illegal conduct.
Reforms the opioid settlement board to provide services and supports to grieving families and include board members who lost a child, sibling, parent or close family member to substance use disorder.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.